PT1621633E - Glicoproteínas produzidas em plantas com supressão da expressão de beta 1,2-xilosiltransferase - Google Patents

Glicoproteínas produzidas em plantas com supressão da expressão de beta 1,2-xilosiltransferase Download PDF

Info

Publication number
PT1621633E
PT1621633E PT51080141T PT05108014T PT1621633E PT 1621633 E PT1621633 E PT 1621633E PT 51080141 T PT51080141 T PT 51080141T PT 05108014 T PT05108014 T PT 05108014T PT 1621633 E PT1621633 E PT 1621633E
Authority
PT
Portugal
Prior art keywords
plants
xylosyltransferase
beta
glycoproteins produced
suppressed expression
Prior art date
Application number
PT51080141T
Other languages
English (en)
Portuguese (pt)
Inventor
Friedrich Altmann
Josef Glössl
Richard Strasser
Jan Mucha
Lukas Mach
Iain B Wilson
Herta Steinkellner
Original Assignee
Josef Glossl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=3672559&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT1621633(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Josef Glossl filed Critical Josef Glossl
Publication of PT1621633E publication Critical patent/PT1621633E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/005—Glycopeptides, glycoproteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1048—Glycosyltransferases (2.4)
    • C12N9/1077—Pentosyltransferases (2.4.2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y204/00—Glycosyltransferases (2.4)
    • C12Y204/02—Pentosyltransferases (2.4.2)
    • C12Y204/02038—Glycoprotein 2-beta-D-xylosyltransferase (2.4.2.38)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01024—Alpha-mannosidase (3.2.1.24)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/0105—Alpha-N-acetylglucosaminidase (3.2.1.50)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01052—Beta-N-acetylhexosaminidase (3.2.1.52)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
PT51080141T 2000-03-03 2001-03-02 Glicoproteínas produzidas em plantas com supressão da expressão de beta 1,2-xilosiltransferase PT1621633E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT0035500A AT409381B (de) 2000-03-03 2000-03-03 Xylosyltransferase-gen

Publications (1)

Publication Number Publication Date
PT1621633E true PT1621633E (pt) 2014-07-18

Family

ID=3672559

Family Applications (1)

Application Number Title Priority Date Filing Date
PT51080141T PT1621633E (pt) 2000-03-03 2001-03-02 Glicoproteínas produzidas em plantas com supressão da expressão de beta 1,2-xilosiltransferase

Country Status (12)

Country Link
US (3) US7205137B2 (enExample)
EP (2) EP1263968B2 (enExample)
JP (2) JP5279976B2 (enExample)
KR (5) KR20080077296A (enExample)
AT (2) AT409381B (enExample)
AU (1) AU781010B2 (enExample)
CA (1) CA2402015C (enExample)
DE (1) DE60115863T3 (enExample)
DK (2) DK1263968T4 (enExample)
ES (2) ES2252208T5 (enExample)
PT (1) PT1621633E (enExample)
WO (1) WO2001064901A1 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2350063T3 (es) 1998-12-09 2011-01-17 Phyton Holdings, Llc Método para fabricación de glicoproteínas que tienen glicosilación de tipo humano.
NZ518532A (en) 1999-10-26 2004-02-27 Plant Res Internat B Transgenic plant expressing mammalian beta-1,4- galactosyltransferase
CA2434364C (en) 2001-01-19 2013-03-19 The Dow Chemical Company Method for secretory production of glycoprotein having human-type sugar chain using plant cell
CA2799805C (en) 2002-03-19 2016-05-17 Stichting Dienst Landbouwkundig Onderzoek Optimizing glycan processing in plants
WO2003078614A2 (en) 2002-03-19 2003-09-25 Plant Research International B.V. Gntiii (udp-n-acethylglucosamine:beta-d mannoside beta (1,4)-n-acethylglucosaminy ltransferase iii) expression in plants
CL2003002461A1 (es) 2002-11-27 2005-01-07 Dow Chemical Company Agroscien Inmunoglobulina que comprende al menos un glicano afucosilado, composicion que la contiene, secuencia nucleotidica y vector que la comprende, procedimiento para producir dicha inmunoglobulina en plantas.
ATE426033T1 (de) 2003-08-11 2009-04-15 Greenovation Biotech Gmbh Promoter sequenzen aus moos und dessen verwendung
MX2008009220A (es) * 2006-01-17 2008-10-10 Biolex Therapeutics Inc Composiciones y metodos para la humanizacion y optimizacion de n-glicanos en plantas.
US20090060921A1 (en) * 2006-01-17 2009-03-05 Biolex Therapeutics, Inc. Glycan-optimized anti-cd20 antibodies
AU2007229061A1 (en) * 2006-03-23 2007-09-27 Bayer Bioscience N.V. Novel nucleotide sequences encoding nicotiana beta-1,2-xylosyltransferase
CN101702919B (zh) 2007-04-17 2014-08-13 基金会农业研究服务中心 植物通过表达非哺乳动物糖基转移酶而表现出哺乳动物类型的糖基化作用
CA2693525C (en) 2007-06-07 2020-09-29 Agriculture And Agri-Food Canada Nanocarrier based transfection and transduction of plant gametophytic cells
EP2789686A1 (en) 2013-04-11 2014-10-15 Greenovation Biotech GmbH Expression of phosphorylated glycoproteins in plants
JP6934666B2 (ja) * 2018-01-18 2021-09-15 国立研究開発法人産業技術総合研究所 植物細胞においてキシロース修飾タンパク質を製造する方法、コアオリゴ糖修飾タンパク質を製造する方法、及びプロテオグリカンを製造する方法
EP3871687A1 (en) 2020-02-27 2021-09-01 eleva GmbH Enzyme replacement therapy for treating pompe disease

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE259378T1 (de) * 1995-11-23 2004-02-15 Cancer Res Campaign Tech Materialien und methoden mit bezug zur identifizierung und sequenzierung des krebs- suszeptilitaetsgens brca2 und dessen anwendungen
AU1808699A (en) * 1997-12-08 1999-06-28 Board Of Trustees Of The University Of Arkansas, The Purified beta1,2-xylosyltransferase and uses thereof
DE19754622A1 (de) † 1997-12-09 1999-06-10 Antje Von Dr Schaewen Pflanzliche GntI-Sequenzen und Verwendung derselben zur Gewinnung von Pflanzen mit verminderter oder fehlender N-Acetylglucosaminyltransferase I (GnTI)-Aktivität
CA2309391A1 (en) * 1997-12-19 1999-07-01 Pharmacia & Upjohn Company Human sel-10 polypeptides and polynucleotides that encode them
US6207811B1 (en) * 1998-03-18 2001-03-27 Karl Tryggvason Nephrin gene and protein
AU5559499A (en) * 1998-08-11 2000-03-06 Darwin Discovery Limited Identification of the gene causing the mouse scurfy phenotype and its human ortholog
EP1033405A3 (en) * 1999-02-25 2001-08-01 Ceres Incorporated Sequence-determined DNA fragments and corresponding polypeptides encoded thereby
BR0014945A (pt) * 1999-10-21 2004-08-31 Monsanto Co Modificação pós-traducional de proteìnas recombinantes produzidas em plantas

Also Published As

Publication number Publication date
KR20080077296A (ko) 2008-08-21
KR20090101981A (ko) 2009-09-29
KR20070058018A (ko) 2007-06-07
JP2004500096A (ja) 2004-01-08
KR100859919B1 (ko) 2008-09-23
US20120331578A1 (en) 2012-12-27
KR100861437B1 (ko) 2008-10-02
DE60115863T3 (de) 2015-01-22
CA2402015A1 (en) 2001-09-07
DK1263968T4 (da) 2014-11-03
WO2001064901A1 (en) 2001-09-07
EP1263968B2 (en) 2014-09-10
DE60115863D1 (de) 2006-01-19
DK1263968T3 (da) 2006-05-01
DK1621633T3 (da) 2014-05-19
CA2402015C (en) 2012-07-17
EP1621633A2 (en) 2006-02-01
US20070186311A1 (en) 2007-08-09
AU4649501A (en) 2001-09-12
ATE312931T1 (de) 2005-12-15
KR101185123B1 (ko) 2012-09-21
ES2252208T3 (es) 2006-05-16
US7205137B2 (en) 2007-04-17
JP5279976B2 (ja) 2013-09-04
EP1621633B1 (en) 2014-04-16
KR20100119005A (ko) 2010-11-08
AU781010B2 (en) 2005-04-28
JP2013116113A (ja) 2013-06-13
EP1263968B1 (en) 2005-12-14
EP1263968A1 (en) 2002-12-11
US20040121325A1 (en) 2004-06-24
ATA3552000A (de) 2001-12-15
DE60115863T2 (de) 2006-08-10
AT409381B (de) 2002-07-25
KR20030030987A (ko) 2003-04-18
EP1621633A3 (en) 2006-02-08
ES2252208T5 (es) 2014-11-04
ES2460672T3 (es) 2014-05-14

Similar Documents

Publication Publication Date Title
PT1621633E (pt) Glicoproteínas produzidas em plantas com supressão da expressão de beta 1,2-xilosiltransferase
CA2315248A1 (en) Protein expression in baculovirus vector expression systems
PL2251353T3 (pl) Homogenne preparaty IL-29
AUPP051497A0 (en) Antimicrobial peptides
CA2033176A1 (en) Growth hormone fusion proteins
ATE218579T1 (de) Zusammensetzungen und methoden zur behandlung von infektionen unter verwendung von indolicidin- analogen
NZ227788A (en) Peptide having growth hormone regulatory effects, and compositions
DE69518910D1 (de) Verfahren zur herstellung von viralen vektoren von mindestens 20kb durch intermolekulare homologe rekombination in einer prokaryotischen zelle
ATE402957T1 (de) Analoge des menschlichen interferon-alpha mit niedriger toxizität
CA2005502A1 (en) Somatotropin analogs
ZA942729B (en) Modified protein and peptide pharmaceuticals.
AU5385486A (en) Biologically active protein compositions and a method of use
DK0614980T3 (da) Trans-dominante TAT-varianter fra humant immundeficiens-virus
EP0349342A3 (en) Polypeptides with cell-spreading activity
AU2308992A (en) Cysteine depleted il-6 muteins
GR3034309T3 (en) IFN--g(b) LIQUID FORMULATIONS
NO971508L (no) Analoger av sur fibroblastvekstfaktor med forökt stabilitet og biologisk aktivitet
AR024430A1 (es) Proteinas insecticidas y combinaciones sinergicas de las mismas
DE60234843D1 (de) Modifizierte peptide und deren verwendung zur behandlung von autoimmunkrankheiten
AU637589B2 (en) Ancrod proteins, their production and use
DE69534738D1 (de) Leukocyten-aktivierender Faktor
DE60138885D1 (de) Polypeptide mit aktivität der stimulierung von neutrophilen
IT9064501A1 (it) Procedimento ed impianto per l'ottenimento a partire dai sottoprodotti della mecellazione come ossa, grasso, sugna di: - grassi - idrolizzati concentrati proteici; -residuo osseo a bassissimo contenuto in grasso. tutti questi prodotti possono essere
WO2003016490A3 (en) Rna silencing suppression